<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Comparison of clinical and laboratory findings according to respiratory pathogens in children hospitalized due to community-acquired pneumonia</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Variables</th>
    <th>only MP
     <sup>1</sup>
     <break/>(
     <italic>n</italic> = 7455)
    </th>
    <th>MP coinfected with virus
     <sup>2</sup>
     <break/>(
     <italic>n</italic> = 1728)
    </th>
    <th>Adenovirus
     <sup>3</sup>
     <break/>(
     <italic>n</italic> = 680)
    </th>
    <th>Influenza virus
     <sup>4</sup>
     <break/>(
     <italic>n</italic> = 1491)
    </th>
    <th>Metapneumovirus
     <sup>5</sup>
     <break/>(
     <italic>n</italic> = 1287)
    </th>
    <th>RSV
     <sup>6</sup>
     <break/>(
     <italic>n</italic> = 4521)
    </th>
    <th>
     <italic>P</italic> value
    </th>
    <th>Post hoc test
     <sup>a</sup>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Age (month), mean ± SD</td>
    <td>66.7 ± 39.7</td>
    <td>53.3 ± 37.3</td>
    <td>34.1 ± 28.0</td>
    <td>54.4 ± 46.0</td>
    <td>28.1 ± 28.2</td>
    <td>15.9 ± 21.0</td>
    <td>&lt; 0.0001</td>
    <td>1 &gt; 4 = 2 &gt; 3 &gt; 5 &gt; 6</td>
   </tr>
   <tr>
    <td>Sex (male), No. (%)</td>
    <td>3680 (49.4)</td>
    <td>862 (49.9)</td>
    <td>389 (57.2)</td>
    <td>828 (55.5)</td>
    <td>692 (53.8)</td>
    <td>2551 (56.4)</td>
    <td>&lt; 0.0001</td>
    <td>2 &gt; 3 = 6 = 4 = 5 &gt; 1</td>
   </tr>
   <tr>
    <td>Duration of Hospitalization (hrs), mean ± SD</td>
    <td>159.9 ± 227.4</td>
    <td>174.2 ± 339.8</td>
    <td>181.4 ± 250.4</td>
    <td>136.3 ± 161.2</td>
    <td>148.6 ± 166.0</td>
    <td>162.2 ± 238.6</td>
    <td>&lt; 0.0001</td>
    <td>3 = 2 = 6 = 1 ≥ 5 ≥ 4</td>
   </tr>
   <tr>
    <td>Administration of steroid, No. (%)</td>
    <td>1645 (22.1)</td>
    <td>454 (26.3)</td>
    <td>75 (11.0)</td>
    <td>117 (7.9)</td>
    <td>170 (13.2)</td>
    <td>622 (13.8)</td>
    <td>&lt; 0.0001</td>
    <td>2 &gt; 1 &gt; 6 = 5 = 3 &gt; 4</td>
   </tr>
   <tr>
    <td>Oxygen supplementation, No. (%)</td>
    <td>299 (4.0)</td>
    <td>109 (6.3)</td>
    <td>67 (9.9)</td>
    <td>82 (5.5)</td>
    <td>147 (11.4)</td>
    <td>905 (20.0)</td>
    <td>&lt; 0.0001</td>
    <td>6 &gt; 5 &gt; 3 &gt; 2 = 4 = 1</td>
   </tr>
   <tr>
    <td>Ventilator care, No. (%)</td>
    <td>12 (0.2)</td>
    <td>4 (0.2)</td>
    <td>8 (1.2)</td>
    <td>14 (0.9)</td>
    <td>12 (0.9)</td>
    <td>51 (1.1)</td>
    <td>&lt; 0.0001</td>
    <td>3 = 6 &gt; 4 = 5 = 2 = 1</td>
   </tr>
   <tr>
    <td>ICU care, No. (%)</td>
    <td>27 (0.4)</td>
    <td>11 (0.6)</td>
    <td>13 (1.9)</td>
    <td>23 (1.5)</td>
    <td>17 (1.3)</td>
    <td>119 (2.6)</td>
    <td>&lt; 0.0001</td>
    <td>6 ≥ 3 = 4 = 5 = 2 &gt; 1</td>
   </tr>
   <tr>
    <td>WBC (× 10
     <sup>3</sup>/μL), median ± IQR
    </td>
    <td>8275 ± 4700</td>
    <td>8870 ± 5560</td>
    <td>11,810 ± 7155</td>
    <td>7510 ± 4760</td>
    <td>8700 ± 5142.5</td>
    <td>9660 ± 4857.5</td>
    <td>&lt; 0.0001</td>
    <td>3 &gt; 2 &gt; 4 &gt; 6 &gt; 1 = 5</td>
   </tr>
   <tr>
    <td>Neutrophil (%), median ± IQR</td>
    <td>60.1 ± 21.8</td>
    <td>57.6 ± 26.2</td>
    <td>56.2 ± 25.8</td>
    <td>57.5 ± 32.2</td>
    <td>42.3 ± 29.6</td>
    <td>35 ± 28.4</td>
    <td>&lt; 0.0001</td>
    <td>1 &gt; 2 = 3 = 4 &gt; 5 &gt; 6</td>
   </tr>
   <tr>
    <td>Lymphocyte (%), median ± IQR</td>
    <td>28.5 ± 18.8</td>
    <td>31 ± 22.8</td>
    <td>33 ± 25</td>
    <td>29.7 ± 28</td>
    <td>46 ± 27.2</td>
    <td>51.8 ± 26.5</td>
    <td>&lt; 0.0001</td>
    <td>6 &gt; 5 &gt; 2 = 3 = 4 &gt; 1</td>
   </tr>
   <tr>
    <td>Eosinophil (%), median ± IQR</td>
    <td>1.6 ± 3.3</td>
    <td>1.1 ± 2.5</td>
    <td>0.4 ± 1.4</td>
    <td>0.4 ± 1</td>
    <td>0.5 ± 1.2</td>
    <td>1 ± 2</td>
    <td>&lt; 0.0001</td>
    <td>1 &gt; 2 &gt; 6 &gt; 3 = 4 = 5</td>
   </tr>
   <tr>
    <td>Hb, median ± IQR</td>
    <td>12.4 ± 1.2</td>
    <td>12.3 ± 1.2</td>
    <td>11.8 ± 1.2</td>
    <td>12.3 ± 1.5</td>
    <td>12 ± 1.3</td>
    <td>11.9 ± 1.7</td>
    <td>&lt; 0.0001</td>
    <td>1 ≥ 2 = 4 &gt; 5 ≥ 6 ≥ 3</td>
   </tr>
   <tr>
    <td>Platelet (×10
     <sup>3</sup>/μL), median ± IQR
    </td>
    <td>293.0 ± 140.0</td>
    <td>284.0 ± 126.0</td>
    <td>297.0 ± 144.8</td>
    <td>232.0 ± 102.0</td>
    <td>260.0 ± 132.0</td>
    <td>328.0 ± 166.0</td>
    <td>&lt; 0.0001</td>
    <td>6 &gt; 1 ≥ 3 ≥ 2 &gt; 5 &gt; 4</td>
   </tr>
   <tr>
    <td>AST, U/L, median ± IQR</td>
    <td>29.0 ± 9.0</td>
    <td>30.0 ± 9.0</td>
    <td>31.0 ± 8.0</td>
    <td>31.0 ± 9.0</td>
    <td>34.0 ± 8.0</td>
    <td>33.0 ± 8.0</td>
    <td>&lt; 0.0001</td>
    <td>5 ≥ 6 &gt; 3 = 4 = 2 &gt; 1</td>
   </tr>
   <tr>
    <td>ALT, U/L, median ± IQR</td>
    <td>14.0 ± 7.0</td>
    <td>14.0 ± 7.0</td>
    <td>14.0 ± 8.0</td>
    <td>15.0 ± 9.0</td>
    <td>16.0 ± 9.0</td>
    <td>18.0 ± 10.0</td>
    <td>&lt; 0.0001</td>
    <td>6 &gt; 5 = 4 &gt; 3 = 2 = 1</td>
   </tr>
   <tr>
    <td>LDH, U/L, median ± IQR</td>
    <td>479.0 ± 294.5</td>
    <td>475.0 ± 348.5</td>
    <td>516.5 ± 326.8</td>
    <td>467.0 ± 292.5</td>
    <td>549.0 ± 311.0</td>
    <td>540 ± 300</td>
    <td>&lt; 0.0001</td>
    <td>6 &gt; 5 = 3 = 2 = 1 &gt; 4</td>
   </tr>
   <tr>
    <td>CRP, mg/dL, median ± IQR</td>
    <td>2.2 ± 4.8</td>
    <td>1.6 ± 3.8</td>
    <td>2.7 ± 4.9</td>
    <td>1.0 ± 2.6</td>
    <td>1.1 ± 2.8</td>
    <td>0.6 ± 1.8</td>
    <td>&lt; 0.0001</td>
    <td>1 ≥ 3 ≥ 2 &gt; 5 = 4 &gt; 6</td>
   </tr>
   <tr>
    <td>ESR, mm/hr., median ± IQR</td>
    <td>31.0 ± 30.0</td>
    <td>30.0 ± 30.0</td>
    <td>34.0 ± 35.0</td>
    <td>14.0 ± 19.2</td>
    <td>20 ± 23</td>
    <td>15.0 ± 22.0</td>
    <td>&lt; 0.0001</td>
    <td>3 &gt; 1 = 2 &gt; 5 &gt; 6 &gt; 4</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <italic>ALT</italic> alanine aminotransferase, 
   <italic>AST</italic> aspartate aminotransferase, 
   <italic>CRP</italic> C-reactive protein, 
   <italic>ESR</italic> erythrocyte sedimentation rate, 
   <italic>Hb</italic> hemoglobin, 
   <italic>ICU</italic> intensive care unit, 
   <italic>LDH</italic> lactate dehydrogenase, 
   <italic>MP Mycoplasma pneumoniae</italic>, 
   <italic>NA</italic> not applicable, 
   <italic>RSV</italic> respiratory syncytial virus, 
   <italic>SD</italic> standard deviation, 
   <italic>WBC</italic> white blood cell count
  </p>
  <p>
   <sup>a</sup>Group 1, MP pneumonia; group 2, MP co-infected with virus; group 3, adenovirus; group 4, influenza virus; group 5, Metapneumovirus; group 6, RSV; The inequality or equal signs mean the rank order of post hoc analyses
  </p>
  <p>
   <sup>b</sup>Post hoc analyses were used to examine if the characteristics of MP pneumonia groups were statistically significant with chi-squared test. For the continuous variables, one-way ANOVA tests were conducted to compare groups, followed by Mann-Whitney U test
  </p>
 </table-wrap-foot>
</table-wrap>
